CVE-2026-94033 — Katalog CVE

csirt@kutim:~/threat-intel/cve/CVE-2026-94033

CVSS 3.5 · Low EPSS 0,35%

Kerentanan Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting'). Skor CVSS 3.1 3.5 (Low) menurut vuldb.com.

Deskripsi (NVD)

A vulnerability has been found in SourceCodester Drug Recommendation System 1.0. This vulnerability affects unknown code of the file /drug_recommender/Admin/add_user of the component User Management. Such manipulation of the argument txtname/txtemail/txtpassword leads to cross site scripting. It is possible to launch the attack remotely. The exploit has been disclosed to the public and may be used.

Rincian

Terbit di NVD: 20 September 2026
Terakhir diubah: 21 September 2026
Status NVD: Deferred
CVSS 3.1: 3.5 (Low), sumber vuldb.com
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:N/I:L/A:N · uraikan di kalkulator
Jenis kelemahan (CWE): CWE-79: Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
CWE-94: Improper Control of Generation of Code ('Code Injection')
EPSS (30 hari): 0,35% peluang dieksploitasi; lebih tinggi dari 26,5% CVE lain

Produk dan versi terdampak

NVD belum mencantumkan data produk (CPE) untuk CVE ini. Produk yang terdampak biasanya disebut di deskripsi dan di advisory vendor pada daftar referensi.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.